Literature DB >> 8288039

The aldose reductase controversy.

R N Frank1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8288039     DOI： 10.2337/diab.43.2.169

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  9 in total

Review 1.  Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism.

Authors:  Weier Qi; Qian Li; Daniel Gordin; George L King
Journal:  J Mol Med (Berl)       Date:  2018-03-24       Impact factor: 4.599

2.  Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy.

Authors:  Daniel Gordin; Hetal Shah; Takanori Shinjo; Ronald St-Louis; Weier Qi; Kyoungmin Park; Samantha M Paniagua; David M Pober; I-Hsien Wu; Vanessa Bahnam; Megan J Brissett; Liane J Tinsley; Jonathan M Dreyfuss; Hui Pan; Yutong Dong; Monika A Niewczas; Peter Amenta; Thorsten Sadowski; Aimo Kannt; Hillary A Keenan; George L King
Journal:  Diabetes Care       Date:  2019-05-10       Impact factor: 19.112

3.  The Vanderbilt Classification System in the evaluation of diabetic retinopathy patients treated with Alredase.

Authors:  S S Feman; T C Leonard-Martin; J R Redman
Journal:  Trans Am Ophthalmol Soc       Date:  1996

4.  Experimental nonenzymatic glycosylation of vitreous collagens occurs by two pathways.

Authors:  J S Pulido
Journal:  Trans Am Ophthalmol Soc       Date:  1996

5.  Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.

Authors:  Weier Qi; Hillary A Keenan; Qian Li; Atsushi Ishikado; Aimo Kannt; Thorsten Sadowski; Mark A Yorek; I-Hsien Wu; Samuel Lockhart; Lawrence J Coppey; Anja Pfenninger; Chong Wee Liew; Guifen Qiang; Alison M Burkart; Stephanie Hastings; David Pober; Christopher Cahill; Monika A Niewczas; William J Israelsen; Liane Tinsley; Isaac E Stillman; Peter S Amenta; Edward P Feener; Matthew G Vander Heiden; Robert C Stanton; George L King
Journal:  Nat Med       Date:  2017-04-24       Impact factor: 53.440

6.  Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.

Authors:  Mariusz Nowak; Tomasz Wielkoszyński; Bogdan Marek; Beata Kos-Kudła; Elzbieta Swietochowska; Lucyna Siemińska; Jacek Karpe; Dariusz Kajdaniuk; Joanna Głogowska-Szelag; Katarzyna Nowak
Journal:  Clin Exp Med       Date:  2009-12-11       Impact factor: 3.984

Review 7.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

8.  Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy.

Authors:  Mariusz Nowak; Tomasz Wielkoszyński; Bogdan Marek; Beata Kos-Kudła; Elzbieta Swietochowska; Lucyna Siemińska; Dariusz Kajdaniuk; Joanna Głogowska-Szelag; Katarzyna Nowak
Journal:  Clin Exp Med       Date:  2008-09-13       Impact factor: 3.984

Review 9.  Physiological and Pathological Roles of Aldose Reductase.

Authors:  Mahavir Singh; Aniruddh Kapoor; Aruni Bhatnagar
Journal:  Metabolites       Date:  2021-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.